Sarah Gigante undergoes iliac artery surgery, will miss Tour Down Under

WILLUNGA HILL AUSTRALIA JANUARY 14 Sarah Gigante of Australia and AG Insurance Soudal Team attacks at Willunga Hill 370m to win the 8th Santos Womens Tour Down Under 2024 Stage 3 a 934km stage from Adelaide to Willunga Hill 370m UCIWWT on January 14 2024 in Willunga Hill Australia Photo by Tim de WaeleGetty Images
Sarah Gigante (AG Insurance-Soudal) attacks at Willunga Hill on her way to overall victory at 2024 Women’s Tour Down Under (Image credit: Getty Images)

Sarah Gigante announced on social media that she will be sidelined for several months following successful surgery to treat iliac artery endofibrosis. The former Australian road champion and two-time Australian time trial champion will miss the opportunity to chase a national title and also defend her overall win at the Women's Tour Down Under in January.

After struggling with pain in her right leg, Gigante, 24, was diagnosed with endofibrosis on Monday, December 2nd while in Australia.

Lyne Lamoureux

Lyne has been involved in professional cycling for more than 15 years in both news reporting and sports marketing. She founded Podium Insight in 2008, quickly becoming a trusted source for news of the North American professional cycling world. She was the first to successfully use social media to consistently provide timely and live race updates for all fans. She is proud to have covered men's and women's news equally during her tenure at the helm of the site. Her writing has appeared on Cyclingnews and other news sites.